RecruitingPhase 2
An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye
Vanda Pharmaceuticals · NCT07179055
View Study & Apply (opens in a new tab)
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Not accepted (a condition is required)
- Study type
- Interventional · Phase 2
- Target enrollment
- 160
- US sites recruiting
- 2
- Study start
- October 2025
- Record last updated
- September 17, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of dry eye.
Being studied: VSJ-110; Placebo
Conditions: Dry Eye
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Be at least 18 years of age of either gender and any race.
- Provide written informed consent and sign the HIPAA form.
- Be willing and able to follow all instructions and attend all study visits.
Exclusion Criteria
- Use of any of the disallowed medications during the washout and study period.
Recruiting US locations
Vanda Investigational Site
Newport Beach, CA 92663
Site contact: Vanda Pharmaceuticals · 202-734-3400
Vanda Investigational Site
Memphis, TN 38119
Site contact: Vanda Pharmaceuticals · 202-734-3400
Study contacts (from the official record)
- Vanda Pharmaceuticals · 202-734-3400 · clinicaltrials@vandapharma.com